Lorazepam, a benzodiazepine, acts as a positive allosteric modulator of GABA-A receptors, enhancing inhibitory neurotransmission and reducing neuronal excitability in the central nervous system. In Visual Snow Syndrome, it may help mitigate symptoms by dampening hyperactive neural networks and potentially reducing sensory processing abnormalities through its anxiolytic and neuronal stabilizing effects.